With trial win, AbbVie cues up Botox for another cosmetic indication

Already approved as an injection to reduce wrinkles in the forehead and around the eyes—as well as a wide variety of other medical disorders—Botox is in position to expand its cosmetic uses to the moderate to severe form of platysma prominence.

Monday, AbbVie revealed positive results of a second phase 3 trial of Botox for the indication, which can also include disruption of the jawline and the lower part of the face, which is attributed to contraction of the platysma muscle.